Page 13 - Expanded Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Zevra Therapeutics Receives FDA Acceptance of Resubmission of NDA for Arimoclomol as a Treatment for Niemann-Pick Disease Type C

Zevra Therapeutics Receives FDA Acceptance of Resubmission of NDA for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Nichol ochsnerDavid schullNeilf mcfarlaneIgnacio guerrero rosCompany expanded access programEuropean medicines agencyExchange commissionZevra therapeutics incGlobenewswire incDrug administrationNew drug applicationPrescription drug user fee actChief executive officerOrphan drugFast trackBreakthrough therapy

Zevra Therapeutics Appoints Global Medical Leader, Adrian

CELEBRATION, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics.

City ofUnited kingdomIgnacio guerrero rosDavid schullNeilf mcfarlaneNichol ochsnerZevra therapeutics incCompensation committee of zevra board directorsCompany expanded access programGroup viceErasmus university medical centerAdamas pharmaceuticalsErasmus university medical schoolGlobal medical affairs at biomarin pharmaceuticals incExchange commissionClinical research

Zevra Therapeutics Appoints Global Medical Leader, Adrian Quartel, M D , FFPM, as Chief Medical Officer

Zevra Therapeutics Appoints Global Medical Leader, Adrian Quartel, M D , FFPM, as Chief Medical Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomNichol ochsnerIgnacio guerrero rosNeilf mcfarlaneDavid schullClinical researchGlobal medical affairs at biomarin pharmaceuticals incExchange commissionAdamas pharmaceuticalsErasmus university medical schoolErasmus university medical centerGroup viceCompany expanded access programZevra therapeutics incCompensation committee of zevra board directors

Dosing begins in Phase 2a trial testing foralumab nasal spray in MS

Dosing begins in Phase 2a trial testing foralumab nasal spray in MS
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

United statesGabriele cerroneTanuja chitnisMattheww davisTiziana life sciencesAccess programExpanded disability status scaleExpanded access program

RedHill and U S Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola

RedHill and U S Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomSouth africaCoted ivoireMacau generalHong kongIvory coastReza fathiAdi frishRedhill biopharmaJeffrey kugelmanNational institutes of healthUs department of defenseUs army medical researchGilead sciences incProduct development pipelinePrnewswire redhill biopharma ltd